If you are in a mental health crisis, free 24/7 support is available. Call or text 988. If it is an emergency, call 911.
Call or text 988TMS and integrative mental health care in Long Beach
Maybe therapy helped, but only so far. Maybe a medication worked for a while, then stopped. Maybe the side effects made you wonder which was worse, the illness or the prescription. None of that is a verdict on you. It is the record we read first.
Free consultation. Benefits checked before treatment begins.
A different first question
Some people arrive after years of trying to explain why they are still not well.
They have taken the pill. They have changed the dose. They have sat in the chair, week after week, talking through what hurt. They have pushed through work, hidden symptoms from family, held a loved one through episodes that scared everyone. None of that history is a character judgment. It is information.
We read prior treatment for what it tells us: what worked partway, what stopped working, what never quite landed. Sleep, anxiety, trauma, safety, and daily function come into the same picture. From there we discuss whether TMS, PrTMS, ketamine, EMDR, therapy, or medication management is the right next step.
Prior treatment, reframed
What happened before tells us something. Not who you are. What your body and brain tolerated. What helped partway. What never quite landed.
A reasonable place to start. About a third of people who try a first antidepressant reach full remission on it; many do not, and need a second step or a different mechanism.1 We read the trials in detail: which medications, at what dose, for how long, with what response, and at what cost in side effects. That history points toward whether neuromodulation, like TMS, fits next.
Therapy can help and still not be enough on its own. We ask what it clarified, what stayed stuck, and whether EMDR, ketamine-assisted work, or a medication review changes what is available.
The first step here is small: history, safety, coverage, fit. We do not ask anyone to commit to a treatment course before they have read the recommendation and asked their questions.
Treatments
A recommendation depends on clinical evaluation, safety, evidence, and coverage. Some patients need one treatment. Some need coordinated care across neuromodulation, therapy, and medication.
Non-invasive magnetic stimulation for mood-regulating circuits. It is outpatient, non-sedating, and does not circulate through the body like medication.
Personalized TMS informed by EEG data, used when symptoms or history call for a more individualized neuromodulation plan.
A clinically supervised treatment pathway for selected patients with treatment-resistant depression, PTSD, or severe symptoms.
Generic ketamine is used off-label for these conditions. Spravato (esketamine) is the FDA-approved nasal-spray formulation for treatment-resistant depression. We discuss which form, if any, fits during evaluation.
Structured trauma therapy that uses bilateral stimulation to help the brain reprocess painful memories and reduce nervous-system activation.
Talk therapy and medication management remain part of the plan when they are clinically useful. The goal is not to replace every prior tool, but to use the right ones with more context.
Conditions
The diagnosis matters, but it does not explain the whole person. MyNeuPath evaluates symptoms, prior care, medical history, family context, and safety before recommending a path.
What to expect
The consultation is designed to lower the burden of starting. You can ask about fit, safety, cost, insurance, and what records may help before deciding whether to schedule a clinical evaluation.
We ask what you are seeking help with, whether there are urgent safety concerns, and what treatment you have already tried.
We verify benefits, explain prior authorization when it applies, and discuss expected out-of-pocket cost before treatment begins.
A clinician reviews symptoms, history, safety, medication response, and whether TMS, PrTMS, ketamine, EMDR, therapy, or medication management is appropriate.
If treatment fits, we map the schedule, expected time course, what to watch for, and how progress will be tracked.
Evidence, cost, coverage
Clinical credibility includes saying what is known, what depends on evaluation, and what insurance may require.
TMS is FDA-cleared for specific indications including major depressive disorder and OCD protocols. It is not a guaranteed outcome, and fit depends on a clinical evaluation.
Current clinic materials list major insurance plans including Blue Shield, Anthem, Aetna, Cigna, United Healthcare, Kaiser, and Medicare. Many patients pay $0 to $25 per session after coverage, but cost depends on benefits, authorization, and plan rules.
Ketamine requires screening and monitored care. TMS and PrTMS are outpatient and non-sedating for many patients, but device protocols, medical history, and symptom profile still matter.
We will not promise a cure, rush a decision, or suggest that one treatment explains every possible path. Outcomes vary, and recommendations should be made by a clinician who knows your history.
Insurance clarity
Repeated treatment has practical weight. Before a course begins, we discuss benefits, authorization, scheduling, and what your plan may require.
Common per-session range after insurance coverage in current clinic materials. This is not a guarantee. We verify your benefits before treatment begins.
Start with a conversation
The first call can be practical: symptoms, prior treatment, insurance, schedule, and whether a clinical evaluation makes sense. You do not need to write out your whole history in a form.
Call (562) 687 29453646 Long Beach Blvd. Suite 210, Long Beach, CA 90807-6034, United States of America
Monday through Friday, 7:00 AM to 6:00 PM. Consultation availability varies by provider schedule.
Website forms are for consultation requests only. Please do not include urgent medical details or full records. If this is an emergency, call or text 988, call 911, or go to the nearest emergency room.